Search results for: 'list sciences m 2a deaf market cell in 2004'
- Did you mean
- list sciences m 2a deal market cell in 2025
- Related search terms
- market+and+acquisition+deal+and+alliance+of+2017
- market+and+acquisition+deal+and+alliance+of+2010
- market+and+acquisition+deal+and+alliances+of+2024
- market+and+acquisition+deal+and+alliances+of+2004
- market+and+acquisition+deal+and+alliance+of+2024
-
Monoclonal Antibody Collaboration and Licensing Deals 2019-2025November 2025$3,995.00Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Specialty Pharmaceutical Partnering Terms and Agreements 2020-2026March 2026$3,995.00Specialty Pharmaceutical Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter specialty pharmaceutical partnering deals.
Learn More -
Microbiome Collaboration and Licensing Deals 2016-2025May 2025$3,995.00Microbiome Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Antibiotic Collaboration and Licensing Deals 2016-2025July 2025$3,995.00Antibiotic Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Generic Pharmaceutical Partnering Terms and Agreements 2010-2026January 2026$3,995.00Global Generic Pharmaceutical Partnering Terms and Agreements 2010 to 2026 report provides a detailed understanding and analysis of how and why companies enter generic pharmaceutical partnering deals.
Learn More
